US$ 27.29
5-amino-1mq nnmt inhibition mechanism – 50mg (Nicotinamide N-Methyltransferase Inhibitor) – BioPeptics Selective and membrane-permeable small molecule
Description
doi: 10.2337/db18-0780

Reactions were performed with 50 M RHKKAc, a fluorogenic peptide substrate from p53 residues 379382, 500 M NAD + co-substrate, and recombinant human SIRT-1 (NAD + -dependent) enzyme

doi: 10.1046/j.1467-789x.2001.00040.x

The animal data suggests these effects can produce measurable weight loss without requiring reduced food intake

Of greater concern are potential risks from combination use: Hypoglycaemia risk: Retatrutide enhances insulin secretion in a glucose-dependent manner, which carries a low intrinsic hypoglycaemia risk when used alone

doi: 10.1038/nm.3882
